0001179110-21-008096.txt : 20210810 0001179110-21-008096.hdr.sgml : 20210810 20210810190137 ACCESSION NUMBER: 0001179110-21-008096 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210806 FILED AS OF DATE: 20210810 DATE AS OF CHANGE: 20210810 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Simantov Ronit CENTRAL INDEX KEY: 0001871563 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35890 FILM NUMBER: 211161501 MAIL ADDRESS: STREET 1: 1988 CHAPEL STREET CITY: NEW HAVEN STATE: CT ZIP: 06515 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tempest Therapeutics, Inc. CENTRAL INDEX KEY: 0001544227 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 451472564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7000 SHORELINE COURT STREET 2: SUITE 275 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-798-8589 MAIL ADDRESS: STREET 1: 7000 SHORELINE COURT STREET 2: SUITE 275 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Millendo Therapeutics, Inc. DATE OF NAME CHANGE: 20181207 FORMER COMPANY: FORMER CONFORMED NAME: OvaScience, Inc. DATE OF NAME CHANGE: 20120308 3 1 edgar.xml FORM 3 - X0206 3 2021-08-06 1 0001544227 Tempest Therapeutics, Inc. TPST 0001871563 Simantov Ronit TEMPEST THERAPEUTICS, INC. 7000 SHORELINE COURT, SUITE 275 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 /s/ Pierre Lorenzo (Attorney-in-Fact) 2021-08-10 EX-24 2 ex24ronit.txt POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints Stephen Brady, Nicholas Maestas and Pierre Lorenzo of Tempest Therapeutics, Inc. and Laura Berezin,Sepideh Mousakhani, Noel Ripberger-Scheick and Nguyen X. Nguyen of Cooley LLP, or any of them signing singly, with full power of substitution, the undersigned's true and lawful attorney in fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer, director or beneficial owner of more than 10% of a registered class of securities of Tempest Therapeutics, Inc. (the "Company"), Forms 3, 4, and 5 (including any amedments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and the rules thereunder and a Form ID, Uniform Application for Access Codes to File on EDGAR. (2) do and perform any and all acts for an on behalf of the undersigned that may be necessary or desirable to execute such Form 3,4 or 5, or Form ID (including any amendments thereto) and timely file such forms with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any nature whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act. This Power of Attorney shall remain in full force and effect until the earliest to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, (b) revocation by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact, or (c) as to any attorney-in-fact individually, until such attorney-in-fact shall no longer be employed by the Company or Cooley LLP. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this date: 8/7/2021. /s/ Ronit Simantov --------------------------- Ronit Simantov